Search research articles
Contact Us
Filters
Showing results (41-50 of 69) with videos related to
Page
of 7
Sort By:
The Journal of Biological Chemistry
|
January 29, 2003
Synthesis and functional analyses of nuclear clusterin, a cell death protein
Konstantin S Leskov, Dmitry Y Klokov, Jing Li, et al.
AORN Journal
|
March 7, 2003
Using intraoperative radiation therapy--a case study
Mary Ann Domanovic, Malika Ouzidane, Rod J Ellis, et al.
Molecular Cancer Therapeutics
|
May 2, 2006
Methoxyamine potentiates iododeoxyuridine-induced radiosensitization by altering cell cycle kinetics and enhancing senescence
Tao Yan, Yuji Seo, Jane E Schupp, et al.
Cancer Journal (Sudbury, Mass.)
|
September 12, 2003
Overexpression of the R2 subunit of ribonucleotide reductase in human nasopharyngeal cancer cells reduces radiosensitivity
Mei-Ling Kuo, Hwa-Shin Hwang, Patrick R Sosnay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 1, 2004
Differential radiosensitization in DNA mismatch repair-proficient and -deficient human colon cancer xenografts with 5-iodo-2-pyrimidinone-2'-deoxyribose
Yuji Seo, Tao Yan, Jane E Schupp, et al.
Cancer Chemotherapy and Pharmacology
|
June 15, 2007
Toxicology and pharmacokinetic study of orally administered 5-iodo-2-pyrimidinone-2'deoxyribose (IPdR) x 28 days in Fischer-344 rats: impact on the initial clinical phase I trial design of IPdR-mediated radiosensitization
Timothy J Kinsella, Michael T Kinsella, Seongwon Hong, et al.
Molecular Cancer Therapeutics
|
September 16, 2004
CHK1 and CHK2 are differentially involved in mismatch repair-mediated 6-thioguanine-induced cell cycle checkpoint responses
Tao Yan, Anand B Desai, James W Jacobberger, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 11, 2009
Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients
Yuji Seo, Michael T Kinsella, Harry L Reynolds, et al.
Radiation Research
|
October 20, 2010
Ribonucleotide reductase inhibition enhances chemoradiosensitivity of human cervical cancers
Charles A Kunos, Tomas Radivoyevitch, John Pink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2010
Phase I trial of pelvic radiation, weekly cisplatin, and 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) for locally advanced cervical cancer
Charles A Kunos, Steven Waggoner, Vivian von Gruenigen, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 69) with videos related to
Sort By:
Page
of 7
The Journal of Biological Chemistry
|
January 29, 2003
Synthesis and functional analyses of nuclear clusterin, a cell death protein
Konstantin S Leskov, Dmitry Y Klokov, Jing Li, et al.
AORN Journal
|
March 7, 2003
Using intraoperative radiation therapy--a case study
Mary Ann Domanovic, Malika Ouzidane, Rod J Ellis, et al.
Molecular Cancer Therapeutics
|
May 2, 2006
Methoxyamine potentiates iododeoxyuridine-induced radiosensitization by altering cell cycle kinetics and enhancing senescence
Tao Yan, Yuji Seo, Jane E Schupp, et al.
Cancer Journal (Sudbury, Mass.)
|
September 12, 2003
Overexpression of the R2 subunit of ribonucleotide reductase in human nasopharyngeal cancer cells reduces radiosensitivity
Mei-Ling Kuo, Hwa-Shin Hwang, Patrick R Sosnay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 1, 2004
Differential radiosensitization in DNA mismatch repair-proficient and -deficient human colon cancer xenografts with 5-iodo-2-pyrimidinone-2'-deoxyribose
Yuji Seo, Tao Yan, Jane E Schupp, et al.
Cancer Chemotherapy and Pharmacology
|
June 15, 2007
Toxicology and pharmacokinetic study of orally administered 5-iodo-2-pyrimidinone-2'deoxyribose (IPdR) x 28 days in Fischer-344 rats: impact on the initial clinical phase I trial design of IPdR-mediated radiosensitization
Timothy J Kinsella, Michael T Kinsella, Seongwon Hong, et al.
Molecular Cancer Therapeutics
|
September 16, 2004
CHK1 and CHK2 are differentially involved in mismatch repair-mediated 6-thioguanine-induced cell cycle checkpoint responses
Tao Yan, Anand B Desai, James W Jacobberger, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 11, 2009
Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients
Yuji Seo, Michael T Kinsella, Harry L Reynolds, et al.
Radiation Research
|
October 20, 2010
Ribonucleotide reductase inhibition enhances chemoradiosensitivity of human cervical cancers
Charles A Kunos, Tomas Radivoyevitch, John Pink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2010
Phase I trial of pelvic radiation, weekly cisplatin, and 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) for locally advanced cervical cancer
Charles A Kunos, Steven Waggoner, Vivian von Gruenigen, et al.
Page
of 7